SLC40A1 and cancer: Over the last years, a number of studies have shown that the levels of Fpn are reduced in several cancer cells compared to their nonmalignant counterparts, so that Fpn downregulation appears as a common strategy that a variety of cancer cells adopt to enhance intracellular iron availability (39).